VEGFA and age-related macular degeneration: For treating SMH secondary to AMD, many non-surgical and surgical methodologies have been proposed, including observation, intravitreal anti-vascular endothelial growth factor (VEGF) injection, pneumatic displacement, subretinal or intravitreal tissue plasminogen activator (t-PA) injection, and photodynamic therapy6–12.